Clinical Trial: Study on the psychological effects of the test beverage (Japan)

Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055696) titled 'Study on the psychological effects of the test beverage' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Single blind -investigator(s) and assessor(s) are blinded Control - Placebo Primary Sponsor: Institute - HUMA R&D CORP Condition: Condition - Healthy subjects Classification by malignancy - Others G...


Clinical Trial: Role of Nebulized dexmedetomidine in Reducing Patient Cough and Discomfort in Flexible Bronchoscopy: a randomized double-blind study (Japan)

Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057496) titled 'Role of Nebulized dexmedetomidine in Reducing Patient Cough and Discomfort in Flexible Bronchoscopy: a randomized double-blind study' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - faculty of medicine - menoufia unive...


Clinical Trial: Evaluation of efficiency and safety for lascufloxacin drip infusion use for atypical pneumonia,including mycoplasma ,and legionella in the Saitama western area (Japan)

Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059212) titled 'Evaluation of efficiency and safety for lascufloxacin drip infusion use for atypical pneumonia,including mycoplasma ,and legionella in the Saitama western area' on Oct. 2. Study Type: Observational Primary Sponsor: Institute - saitama medical university Condition: Condition - atypical pneumonia,including mycoplasma ,and legionella Classification by malignancy - Others G...


Clinical Trial: Evaluation of the Effects of Continued Consumption of the Study Food on Sleep: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial (Japan)

Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059263) titled 'Evaluation of the Effects of Continued Consumption of the Study Food on Sleep: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - IMEQRD Co. Ltd. Condit...


Clinical Trial: Study on the psychological effects of the test beverage (Japan)

Tokyo, Oct. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055697) titled 'Study on the psychological effects of the test beverage' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Single blind -investigator(s) and assessor(s) are blinded Control - Placebo Primary Sponsor: Institute - HUMA R&D CORP Condition: Condition - Healthy subjects Classification by malignancy - Others G...


Clinical Trial: Data collection study on a fundus diagnosis support program using a portable fundus camera (Japan)

Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059264) titled 'Data collection study on a fundus diagnosis support program using a portable fundus camera' on Oct. 2. Study Type: Observational Primary Sponsor: Institute - Hirohsima University Condition: Condition - glaucoma Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - This study utilizes a handheld fundus camera for healthcare pr...


Clinical Trial: IMBRUVICA Capsules 140mg Specified drug-use survey in patients with WM/LPL  (Japan)

Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059271) titled 'IMBRUVICA Capsules 140mg Specified drug-use survey in patients with WM/LPL' on Oct. 2. Study Type: Observational Primary Sponsor: Institute - Janssen Pharmaceutical K.K. Condition: Condition - primary Waldenstrom's macroglobulinemia / lymphoplasmacytic lymphoma Classification by malignancy - Malignancy Genomic information - NO Objective: Narrative objectives1 - To exam...


Clinical Trial: A Multicenter Phase II Study Evaluating the Efficacy of Single-Fraction 8 Gy Radiotherapy for Bleeding Gastrointestinal Malignancies (Japan)

Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059269) titled 'A study to see if one session of radiation therapy can stop bleeding from cancers in the digestive tract' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Historical Primary Sponsor: Institute - Hiroshima University Condition: Condition - Bleeding primary or postope...


Clinical Trial: Development of a home program based on dual-task training of singing and finger movements for elderly people and its effect on cognitive function (Japan)

Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059267) titled 'Development of a home program based on dual-task training of singing and finger movements for elderly people and its effect on cognitive function' on Oct. 2. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - Waseda University Condition:...


JAPAN FAIR TRADE COMMISSION SIGNS MEMORANDUM ON COOPERATION WITH THE U.K. COMPETITION AND MARKETS AUTHORITY

TOKYO, Oct. 1 -- Japan Fair Trade Commission issued the following press release: The Japan Fair Trade Commission (hereinafter, "JFTC"), on 30 September 2025, in Ottawa, Canada, signed a Memorandum on Cooperation (hereinafter, "MoC") with the Competition and Markets Authority (hereinafter, "CMA"), which is the competition authority of the United Kingdom. The signers and outline of this MoC are as follows: 1. Signers JFTC: Mr. Eiji Chatani, Chair, Chair CMA: Mr. Chris Prevett, General Counsel ...